Prelude Capital Management, LLC Iradimed Corp Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$18.68 - $24.35 $7,472 - $9,740	-400 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.08 - $27.67 $3,215 - $5,534	-200 Reduced 33.33%	400 $9,000
Q4 2019 Feb 14, 2020	BUY	$21.11 - $25.92 $12,666 - $15,552	600 New	600 $14,000
Q2 2019 Aug 14, 2019	SELL	$19.6 - $29.31 $5,899 - $8,822	-301 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$20.63 - $34.04 $6,209 - $10,246	301 New	301 $7,000

Q3 2018 Nov 14, 2018	SELL	$20.6 - $37.15 $6,180 - $11,145	-300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.15 - $20.75 $4,245 - $6,225	300 New	300 $6,000
Q1 2018 May 15, 2018	SELL	$13.0 - $15.8 $84,500 - $102,700	-6,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$10.0 - $15.7 $65,000 - $102,050	6,500	6,500 $98,000

127

6.75M

7.7K

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $549M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.